Navigation Links
Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:2/11/2013

Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment.  Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India. The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens.  The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA. 

The Aethlon Hemopurifier® and Cancer

In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer.  Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the development of drug resistance.  By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.

About RetailInvestorConferences.com

Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC) PR Newswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for pres
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
2. Aethlon Medical Discloses CEO Interview
3. Aethlon Medical (AEMD) Note: Extracorporeal Methods to Reduce Inflammation in Sepsis
4. Aethlon Medical To Present Today At The 15th International Conference On Dialysis
5. Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
6. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
7. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
8. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
9. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
10. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
11. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... Oct. 17, 2014 With the recent ... function has come across several challenges in creating ... managing globalization.  The Medical ... dedicated to providing benchmarking and best practices across ... is a service composed of three stages: 1) ...
(Date:10/17/2014)... 17, 2014  Hanger, Inc. (NYSE: HGR ... results of operations for the quarter ended September 30, ... closes.  A conference call to discuss these results is ... November 7, 2014. Those wishing to participate should call ... 14, 2014 by dialing 1-855-859-2056 and referencing Conference ID ...
(Date:10/17/2014)... Conn. , Oct. 17, 2014 UBM Medica ... a leading online community and information resource for neurologists ... disease and Alzheimer disease , with discussions of ... to 1 million Americans have Parkinson disease , more ... dystrophy, or Lou Gehrig disease. Diagnosis can be ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... 12, 2011 Chartwell Pharmaceuticals announced that effective March ... with the Federal Drug Administration agency. The registration, filed ... which is in the process of executing a successful ... Chartwell,s Senior Director of Quality and Regulatory, ...
... Boston Scientific Corporation (NYSE: BSX ) has ... study designed to evaluate its Adapt™ Monorail™ Carotid Stent ... System for treatment of carotid artery disease in patients ... in 2010 and has reached its enrollment goal of ...
Cached Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 2Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 3Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System 4
(Date:10/20/2014)... PA (PRWEB) October 20, 2014 ... Matthew Voicheck as Assistant Director of their ... role in managing the innovative turnkey drug sourcing, ... , Matthew brings over 12 years of industry ... joins Myoderm at the peak of their international ...
(Date:10/20/2014)... October 20, 2014 Final Cut Pro X ... of the Citrus theme for FCPX filmmakers . , ... to describe the Citrus theme” Says Christina Austin, CEO of ... look so professional.” , Citrus comes with all the tools ... template are: four transitions for added style, a title screen ...
(Date:10/20/2014)... Spring, Maryland, USA (PRWEB) October 20, 2014 ... or to track interventions? Here comes a wonderful app ... mobile app development company helped its client ... Intervention more efficiently. The app is designed for iOS ... and iPod touch. This app is optimized for iPhone ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 This ... for Partial Seizure, complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ... Seizure and special features on late-stage and discontinued ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 Visual ... program has just been released to the public ... online body building and fitness community. The commotion ... of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative review. ... of hitting what is commonly known as a ...
Breaking Medicine News(10 mins):Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
... The Botulism bacterium, Clostridium botulinum, produces the world's most lethal ... humanity from the face of the earth! Botox , that ... ,Now, the genome of the organism is exposed. The ... possess the means to escape human defences or resist antibiotics. ...
... books, paints artistically, takes walks and does laundry ... fact that a four-pound disk implanted in his ... ,The procedure to implant the Thoratec HeartMate XVE was ... cardiothoracic surgeon Sinan A. Simsir, M.D., surgical director of ...
... University held a prayer and yoga session during the weekend ... and a lot of learning together," said Kanchan Banerjee, founder ... the event Saturday. ,It has been 17 years ... than 30 students sat barefoot and cross-legged and chanted Sanskrit ...
... alcohol will be introduced in England to ward-off people from ... your limits and drink responsibly will be out by the ... ministers and industry. ,The agreement was first planned ... proper format has been adopted. ,Ministers have insisted ...
... of a heartless establishment. But on the very day a survey ... shame after screaming at a heart attack patient, left lying ... on a trolley after being admitted to the General Hospital in ... ,"I was in agony and scared I was having ...
... might make a show of laying wreaths on war memorials ... war on terror. ,But post traumatic stress disorder (PTSD) is ... veterans have begun to speak out, complaining that the Pentagon ... three months after Marine Maj. John Ruocco returned from Iraq ...
Cached Medicine News:Health News:Genome of Botulism Bacterium Revealed 2Health News:Genome of Botulism Bacterium Revealed 3Health News:Heart-Assist Device Gives Culver City Man a Good Quality of Life 2Health News:Heart-Assist Device Gives Culver City Man a Good Quality of Life 3Health News:UK Introduce New Health Warnings Against Alcohol 2Health News:UK Nurses Complain of Stress, One Quits After Screaming at Heart Attack Patient 2Health News:Suicide Among Returning US Soldiers on the Rise 2Health News:Suicide Among Returning US Soldiers on the Rise 3Health News:Suicide Among Returning US Soldiers on the Rise 4
... Edgeahead Stiletto / MVR knife. 1.1 mm (19G) ... 1.1 mm (19G) Cannula (5/bx, 1 bx/ca). State-of-the-art ... consistently sharp and precise. Sure grip handles have ... tip creates a fluid tight incision for self-sealing ...
... Renu Multiplus No Rub formula is the ... today. All steps in one bottle without ... stores soft contact lenses and removes protein ... multi-purpose solution that contains Hydranate, a special ...
... new level of comfort by enhancing ... the lens and the delicate surface ... sodium hyalunorate, an ingredient that replicates ... eye. With a naturally disappearing preservative, ...
Specially formulated to lubricate and moisten lenses to help relieve irritation and dryness....
Medicine Products: